Have a personal or library account? Click to login
Neurosteroids in Cognitive Disorder - From Well-Known Pharmacological Aspects to a Source of Controversy Cover

Neurosteroids in Cognitive Disorder - From Well-Known Pharmacological Aspects to a Source of Controversy

Open Access
|Aug 2020

Abstract

The nervous system is not just a target organ for synthetic steroids. It is also controlled in a certain manner by steroids synthesized de novo in the brain, at the level of both neurones and glial cells. The impressive recent number of literature studies, clearly demonstrates the presence of enzymes necessary for syntheses of central neurosteroids and also the mechanism by which they act. Neurosteroids play a considerable part as an endogenous modulator of brain function and behaviour processes, and the decrease of their concentration can be associated with the pathophysiology of different neurological diseases accompanied by cognitive disorders such as depression, anxiety, schizophrenia, Alzheimer disease.

DOI: https://doi.org/10.2478/amtsb-2020-0007 | Journal eISSN: 2285-7079 | Journal ISSN: 2285-7079
Language: English
Page range: 23 - 27
Submitted on: Jan 25, 2019
|
Accepted on: Feb 24, 2020
|
Published on: Aug 3, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 Mădălina-Georgiana Bătrînu, Amelia Tero-Vescan, published by Lucian Blaga University of Sibiu
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.